Medaffcon’s Market Access Team Prepares Nordic Projects under the Leadership of Simo Jääskeläinen
Medaffcon’s Market Access team welcomed a new leader in mid-November, as Simo Jääskeläinen returned to his familiar workplace after a six-year hiatus.
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish Market Access scene at the moment. Medaffcon has been studying the agreements, their application and experiences in using them and has also been participating in building several risk-sharing agreements in Finland, both in ambulatory care (with Pharmaceutical Pricing Board) and hospital care (with hospitals).
Learn more about RSA’s from the interview with Pekka Männistö from the video below.
Market Access, pricing and reimbursement of medicines in Finland – This article provides information of the market access options and current pricing system in Finland, in ambulatory and hospital care.
Medaffcon’s Market Access team welcomed a new leader in mid-November, as Simo Jääskeläinen returned to his familiar workplace after a six-year hiatus.
Sweden and Finland are leaders in developing and applying health technology and provide ideal environments for conducting Health Technology Assessments (HTA) for medical devices.
Are you employed in the pharmaceutical industry and seeking insights into your product's position within the Finnish market? Then Patient Dynamics is the ideal tool for you. Developed by Medaffcon, Patient Dynamics caters to the needs of pharmaceutical companies by providing precise information for sales and marketing decision-making.